Combination of chemotherapy and photodynamic therapy using graphene oxide as drug delivery system
- PMID: 24792568
- DOI: 10.1016/j.jphotobiol.2014.04.010
Combination of chemotherapy and photodynamic therapy using graphene oxide as drug delivery system
Abstract
Previous research indicated that graphene oxide (GO) can be used to deliver photosensitive anticancer drug, Hypocrellin A (HA), in photodynamic therapy (PDT). However, the anticancer activity of HA was obviously decreased after been loaded on GO. To solve this problem, a chemotherapy drug, 7-ethyl-10-hydroxycamptothecin (SN-38), was co-loaded on the HA loaded GO (HA/SN-38/GO) as a multimodal carrier for the synergistic combination of PDT and chemotherapy for cancer. In vitro results showed that the combination therapy exhibited a synergistic antiproliferative effect compared with PDT and chemotherapy alone. Therefore, HA/SN-38/GO delivery system has the potential to offer dual therapies for the synergistic combination of PDT and chemotherapy for the treatment of cancer.
Keywords: 7-Ethyl-10-hydroxycamptothecin; Combination therapy; Graphene oxide; Hypocrellin A.
Copyright © 2014 Elsevier B.V. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
